Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Repetitive Transcranial Magnetic Stimulation

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Completed4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Repetitive Transcranial Magnetic Stimulation1
  • Anodal Tdcs1
  • Stimulus Type1
  • Visual Skillsbased Occupational Therapy Program1
  • Checklist1

Active Sponsors

  • Medipol University2
  • Brigham and Women's Hospital1
  • University of California, San Francisco1
  • National Eye Institute (NEI)1

Top Investigators

Related Conditions

  • Tdcs1
  • Visual Cortical Plasticity1
  • Incidental Findings1
  • Visual Deficiencies1
  • Visual Search1

Activity Timeline